MARKET

MEDS

MEDS

TRXADE GROUP, INC.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.13
+0.08
+1.51%
Opening 12:01 09/21 EDT
OPEN
5.11
PREV CLOSE
5.05
HIGH
5.13
LOW
5.00
VOLUME
39.00K
TURNOVER
--
52 WEEK HIGH
11.60
52 WEEK LOW
4.010
MARKET CAP
41.35M
P/E (TTM)
-40.6204
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Trxade Group to Present at Upcoming Investor Conferences in September
TAMPA, FL, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, will participate in the following investor conferences during the month of September 2020: the Colliers Institutional Investor Conference on September 10,
GlobeNewswire · 09/03 21:15
Trxade Group, Inc. -Shareholder Analyst Call
The following slide deck was published by Trxade Group, Inc. in conjunction with this event.
Seekingalpha · 09/03 17:11
Trxade Group, Inc. (MEDS) Investor Presentation - Slideshow
The following slide deck was published by Trxade Group, Inc. in conjunction with this event.
Seekingalpha · 09/03 17:11
Trxade Group to Present at LD Micro 500 Virtual Investor Conference
TAMPA, FL, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that management will present at the LD 500 virtual investor conference, hosted by LD Micro and taking place virtually September 1 – 4, 2020
GlobeNewswire · 08/24 13:05
Trxade Group Announces Launch Of Bonum+ B2B Platform
Benzinga · 08/11 12:06
Trxade Group Announces Launch Of Bonum+ B2B Platform
Benzinga · 08/11 12:06
Sonoma Pharmaceuticals leads healthcare gainers; Aphria and Soligenix among losers
Seeking Alpha · 07/29 15:00
Trxade Group, Inc. (TRXD) CEO Suren Ajjarapu on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha · 07/29 05:42
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MEDS stock price target is 11.25 with a high estimate of 12.00 and a low estimate of 10.50.
EPS
Institutional Holdings
Institutions: 12
Institutional Holdings: 700.55K
% Owned: 8.69%
Shares Outstanding: 8.07M
TypeInstitutionsShares
Increased
3
140.82K
New
7
106.15K
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Internet Services
-1.48%
Software & IT Services
-0.86%
Key Executives
Chairman/Chief Executive Officer/Secretary/Director
Surendra Ajjarapu
President/Chief Operating Officer/Director
Prashant Patel
Chief Financial Officer
Howard Doss
Corporate Executive
Ashton Maaraba
Independent Director
Donald Fell
Independent Director
Michael Peterson
Independent Director
Pamela Tenaerts
  • Dividends
  • Splits
  • Insider Activity
No Data

Analyst Price Target

The average MEDS stock price target is 11.25 with a high estimate of 12.00 and a low estimate of 10.50.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About MEDS
Trxade Group, Inc. is an integrated pharmaceutical services company that combines a Web-based purchasing platform for transactions between independent pharmacists and drug manufacturers. The Company provides specialty pharmacy, warehouse and drug delivery services for consumers. It provides e-commerce technology platform with buyer/seller pricing algorithms, product availability and data analytics features. It operates a specialty pharmacy for consumers throughout the United States, as well as a Delivmeds mobile application (delivmeds.com), and telemedicine portal (bonumhealth.com) that enables home delivery.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Trxade Group Inc stock information, including NASDAQ:MEDS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEDS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MEDS stock methods without spending real money on the virtual paper trading platform.